2020 Pediatric Research Forum Poster Session

Document Type


Publication Date




Lamotrigine is a broad-spectrum anti-epileptic drug with a good safety profile used to treat general and focal epilepsy. Toxicity is uncommon and usually mild, and symptoms usually include rash, headache, nausea, abdominal pain, somnolence, dizziness, and aggravated seizure activity. More severe adverse reactions are rare, but have been reported and include encephalopathy, hypotension, wide complex tachycardia, cardiac arrest, and death. Lamotrigine drug levels do not consistently correlate with either therapeutic effect or toxicity, though higher levels are thought to have a higher risk of toxicity. Also, the level is typically a send out test with a 1 to 3 day turnaround time. This case report details a case of Lamotrigine toxicity in a thirteen-year-old Hispanic female with moderately well-controlled focal epilepsy presenting with acute florid pulmonary edema and fluid refractory vasodilatory shock. These symptoms have not been reported together elsewhere in the pediatric literature. By expanding upon the known presentation of Lamotrigine toxicity in children, the time to diagnosis for future cases may be shortened, providers may avoid anchoring bias, and morbidity may decrease.


Presented at the Annual Pediatric Research Forum Poster session. Contact Anjali Subbaswamy ASubbaswamy@salud.unm.edu for questions.

Included in

Pediatrics Commons



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.